Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00617019 · ClinicalTrials.gov registry record
Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)
A clinical trial of Parkinson Disease, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- 3,234
- Enrollment target
- 20
- Study locations
NCT00617019 is a study of Parkinson Disease that has completed, run by Boehringer Ingelheim. The registered enrollment target is 3,234 participants, below the 5,316-participant average among 297 other Parkinson Disease trials with a reported enrollment target (39% lower). The trial reports 20 study locations across 12 states.
The verdict
NCT00617019, a study of Parkinson Disease, has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- 3,234 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose is to explore the frequency of impulse control disorders in Parkinson's patients treated with different Parkinson's medications.
Conditions Studied
Study Locations (20)
California
- 248.619.01018 Margolin Brain Institute - Fresno
- 248.619.01031 Pacific Neuroscience Medical Group, Inc. - Oxnard
- 248.619.01016 San Francisco VA PD Research, Education, & Clinical Center - San Francisco
- 248.619.01023 The Parkinson's Institute - Sunnyvale
Arizona
- 248.619.01034 Neurological Physicians of Arizona - Gilbert
- 248.619.01007 Mayo Clinic - Scottsdale - Scottsdale
- 248.619.01025 Sun Health Research Institute - Sun City
Connecticut
- 248.619.01027 Associated Neurologists, P.C. - Danbury
- 248.619.01013 Molecular NeuroImaging - New Haven
Florida
- 248.619.01020 Parkinson's Disease and Movement Disorders of Boca Raton - Boca Raton
- 248.619.01009 University of Florida - Gainesville
Georgia
- 248.619.01035 Emory University - Atlanta
- 248.619.01006 Medical College of Georgia - Augusta
Colorado
- 248.619.01021 Boehringer Ingelheim Investigational Site - Englewood
Illinois
- 248.619.01014 Northwestern University - Chicago
Kansas
- 248.619.01001 The University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,234 participants |
| Start Date | 2006-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00617019
The ClinicalTrials.gov registry entry for NCT00617019 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,234 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,316-participant average among 297 other Parkinson Disease trials with a reported enrollment target (39% lower). The listed sponsor is Boehringer Ingelheim, which has 515 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00617019 reports 20 study locations spanning 12 distinct geographic areas - top geographies include California, Arizona, Connecticut.
Frequently Asked Questions
What is clinical trial NCT00617019 about?
NCT00617019 is a clinical study titled "Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)". The purpose is to explore the frequency of impulse control disorders in Parkinson's patients treated with different Parkinson's medications.
What is the current status of trial NCT00617019?
This trial is currently completed. The enrollment target is 3,234 participants. The study started on 2006-09.
What conditions does trial NCT00617019 study?
This clinical trial studies the following conditions: Parkinson Disease.
Who is sponsoring clinical trial NCT00617019?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00617019 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.